The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer

The definitive characterization of common cancer stem cell (CSCs) subpopulations in breast cancer subtypes with distinct genotypic and phenotypic features remains an ongoing challenge. In this study, we have used a non-biased genome wide screening approach to identify transcriptional networks that m...

Bibliografske podrobnosti
Main Authors:	Walsh, CA, Akrap, N, Garre, E, Magnusson, Y, Harrison, H, Andersson, D, Jonasson, E, Rafnsdottir, S, Choudhry, H, Buffa, F, Ragoussis, J, Ståhlberg, A, Harris, A, Landberg, G
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2020

Podobne knjige/članki

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
od: Claire A Walsh, et al.
Izdano: (2020-01-01)

Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway
od: Yasuhiro Kato, et al.
Izdano: (2024-06-01)

Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools
od: Nina Akrap, et al.
Izdano: (2016-01-01)

Proteomics of cell‐free breast cancer scaffolds identify clinically relevant imprinted proteins and cancer‐progressing properties
od: Anna Gustafsson, et al.
Izdano: (2024-06-01)

Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
od: Sara Rhost, et al.
Izdano: (2018-11-01)

Expression of HMGCS2 and its correlation with clinopathological characteristics in bladder cancer
od: ZHU Shuai, et al.
Izdano: (2021-12-01)

Inhibition of Lung Squamous Cancer Target HMGCS1 Promotes Cellular Ferroptosis
od: Yinyun NI, et al.
Izdano: (2024-05-01)

Hmgcs2 is the hub gene in diabetic cardiomyopathy and is negatively regulated by Hmgcs2, promoting high glucose‐induced cardiomyocyte injury
od: Ying Wang, et al.
Izdano: (2024-03-01)

Differentially expressed miRNAs in Luminal and Basal-like breast cancer
od: Ming-Juan ZHAO, et al.
Izdano: (2021-06-01)

Mevalonate Metabolism in Cancer Stemness and Trained Immunity
od: Georg Gruenbacher, et al.
Izdano: (2018-09-01)

Mevalonate metabolism governs cancer immune surveillance
od: Georg Gruenbacher, et al.
Izdano: (2017-10-01)

The Effect of Hypoxic and Normoxic Culturing Conditions in Different Breast Cancer 3D Model Systems
od: Andreas Svanström, et al.
Izdano: (2021-11-01)

Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in Yarrowia lipolytica
od: Monireh Marsafari, et al.
Izdano: (2020-06-01)

HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
od: Fat-Moon Suk, et al.
Izdano: (2022-11-01)

The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
od: Borja Guerra, et al.
Izdano: (2021-02-01)

Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer
od: Zongtai Zheng, et al.
Izdano: (2025-02-01)

Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features
od: Maria Carmen Leiva, et al.
Izdano: (2023-12-01)

Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
od: Karoline Berger, et al.
Izdano: (2021-02-01)

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
od: Andy Göbel, et al.
Izdano: (2020-07-01)

Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
od: Linyuan Xue, et al.
Izdano: (2020-08-01)

Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker
od: Kejian Zou, et al.
Izdano: (2019-01-01)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
od: Hoffmann Georg F, et al.
Izdano: (2006-04-01)

Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis
od: Maria B. Padua, et al.
Izdano: (2018-05-01)

Targeting HMGCS1 restores chemotherapy sensitivity in acute myeloid leukemia
od: Cheng Zhou, et al.
Izdano: (2024-07-01)

A Luminous Precursor in the Extremely Bright GRB 230307A
od: S. Dichiara, et al.
Izdano: (2023-01-01)

Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study
od: Humberto Parada, et al.
Izdano: (2017-12-01)

Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts
od: Susann Busch, et al.
Izdano: (2017-04-01)

Immunohistochemical Evaluation of Basal and Luminal Markers in Bladder Cancer: A Study from a Single Institution
od: Anh Toan Do, et al.
Izdano: (2024-12-01)

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
od: Vipulkumar Dadhania, et al.
Izdano: (2016-10-01)

Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers.
od: Doris Kim, et al.
Izdano: (2016-01-01)

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer
od: Nicholas Borcherding, et al.
Izdano: (2015-06-01)

HMGCS2 and AMACR as potential targets linking mitochondrial dysfunction and ulcerative colitis
od: Rui Zhu, et al.
Izdano: (2024-12-01)

Liver HMGCS2 is critical in the maintenance of liver lipid homeostasis during fasting
od: Yunfeng Zhou, et al.
Izdano: (2023-05-01)

Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis
od: Shaza Asif, et al.
Izdano: (2022-07-01)

KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis
od: Weilong Yao, et al.
Izdano: (2020-06-01)

The mevalonate pathway in <it>C. Elegans</it>
od: Rauthan Manish, et al.
Izdano: (2011-12-01)

Mevalonate Metabolism in Immuno-Oncology
od: Georg Gruenbacher, et al.
Izdano: (2017-12-01)

Expression of housekeeping genes varies depending on mevalonate pathway inhibition in cancer cells
od: Nanami Irie, et al.
Izdano: (2023-07-01)

NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer
od: Zefu Liu, et al.
Izdano: (2023-08-01)

Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer
od: Natalia Ricco, et al.
Izdano: (2019-09-01)